88 related articles for article (PubMed ID: 35442721)
1. Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2.
Kluźniak W; Szymiczek A; Rodrigue A; Wokołorczyk D; Rusak B; Stempa K; Huzarski T; Gronwald J; Lubiński J; Zamani N; Zhang S; Masson JY; Narod SA; ; Cybulski C; Akbari MR
JCO Precis Oncol; 2022 Apr; 6():e2100450. PubMed ID: 35442721
[TBL] [Abstract][Full Text] [Related]
2. A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
Zamani N; Szymiczek A; Shakeri R; Poustchi H; Pourshams A; Narod S; Malekzadeh R; Akbari MR
PLoS One; 2023; 18(11):e0292611. PubMed ID: 37943872
[TBL] [Abstract][Full Text] [Related]
3. Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
Rafnar T; Sigurjonsdottir GR; Stacey SN; Halldorsson G; Sulem P; Pardo LM; Helgason H; Sigurdsson ST; Gudjonsson T; Tryggvadottir L; Olafsdottir GH; Jonasson JG; Alexiusdottir K; Sigurdsson A; Gudmundsson J; Saemundsdottir J; Sigurdsson JK; Johannsdottir H; Uitterlinden A; Vermeulen SH; Galesloot TE; Allain DC; Lacko M; Sigurgeirsson B; Thorisdottir K; Johannsson OT; Sigurdsson F; Ragnarsson GB; Isaksson H; Hardardottir H; Gudbjartsson T; Gudbjartsson DF; Masson G; Kiemeney LAML; Ewart Toland A; Nijsten T; Peters WHM; Olafsson JH; Jonsson S; Thorsteinsdottir U; Thorleifsson G; Stefansson K
J Natl Cancer Inst; 2018 Sep; 110(9):967-974. PubMed ID: 29767749
[TBL] [Abstract][Full Text] [Related]
4. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
Gaudet MM; Kirchhoff T; Green T; Vijai J; Korn JM; Guiducci C; Segrè AV; McGee K; McGuffog L; Kartsonaki C; Morrison J; Healey S; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Gauthier-Villars M; Sobol H; Longy M; Frenay M; GEMO Study Collaborators ; Hogervorst FB; Rookus MA; Collée JM; Hoogerbrugge N; van Roozendaal KE; ; Piedmonte M; Rubinstein W; Nerenstone S; Van Le L; Blank SV; Caldés T; de la Hoya M; Nevanlinna H; Aittomäki K; Lazaro C; Blanco I; Arason A; Johannsson OT; Barkardottir RB; Devilee P; Olopade OI; Neuhausen SL; Wang X; Fredericksen ZS; Peterlongo P; Manoukian S; Barile M; Viel A; Radice P; Phelan CM; Narod S; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Toland AE; Montagna M; D'Andrea E; Friedman E; Laitman Y; Borg A; Beattie M; Ramus SJ; Domchek SM; Nathanson KL; Rebbeck T; Spurdle AB; Chen X; Holland H; ; John EM; Hopper JL; Buys SS; Daly MB; Southey MC; Terry MB; Tung N; Overeem Hansen TV; Nielsen FC; Greene MH; Mai PL; Osorio A; Durán M; Andres R; Benítez J; Weitzel JN; Garber J; Hamann U; ; Peock S; Cook M; Oliver C; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Walker L; Eason J; Barwell J; Godwin AK; Schmutzler RK; Wappenschmidt B; Engert S; Arnold N; Gadzicki D; Dean M; Gold B; Klein RJ; Couch FJ; Chenevix-Trench G; Easton DF; Daly MJ; Antoniou AC; Altshuler DM; Offit K
PLoS Genet; 2010 Oct; 6(10):e1001183. PubMed ID: 21060860
[TBL] [Abstract][Full Text] [Related]
6. A common missense variant in BRCA2 predisposes to early onset breast cancer.
Górski B; Narod SA; Lubinski J
Breast Cancer Res; 2005; 7(6):R1023-7. PubMed ID: 16280055
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in ALDH2 predict risk of ischemic stroke in a Chinese population.
Cheng X; Xu J; Gu M; Wang M; Sun B; Li Z; Ni G; Wang G; Weng Z; Shi Y; Zhang Z; Liu X
Gene; 2018 Dec; 678():49-54. PubMed ID: 30077765
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
[TBL] [Abstract][Full Text] [Related]
9. Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.
Thompson ER; Gorringe KL; Rowley SM; Li N; McInerny S; Wong-Brown MW; Devereux L; Li J; ; Trainer AH; Mitchell G; Scott RJ; James PA; Campbell IG
Sci Rep; 2015 Oct; 5():14800. PubMed ID: 26455428
[TBL] [Abstract][Full Text] [Related]
10. Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
Kuroda A; Hegab AE; Jingtao G; Yamashita S; Hizawa N; Sakamoto T; Yamada H; Suzuki S; Ishii M; Namkoong H; Asakura T; Ozaki M; Yasuda H; Hamamoto J; Kagawa S; Soejima K; Betsuyaku T
Respir Res; 2017 Apr; 18(1):69. PubMed ID: 28431562
[TBL] [Abstract][Full Text] [Related]
11. The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations.
Adamson AW; Ding YC; Mendez-Dorantes C; Bailis AM; Stark JM; Neuhausen SL
Mol Oncol; 2020 Jun; 14(6):1124-1133. PubMed ID: 32175645
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
Abbas S; Siddique A; Shahid N; Khan RT; Fatima W
Breast Cancer; 2019 May; 26(3):365-372. PubMed ID: 30430339
[TBL] [Abstract][Full Text] [Related]
13. The Aldehyde Dehydrogenase ALDH2*2 Allele, Associated with Alcohol Drinking Behavior, Dates Back to Prehistoric Times.
Lin CL; Chien RN; Chen LW; Huang TS; Shyu YC; Yeh CT; Liang KH
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572589
[TBL] [Abstract][Full Text] [Related]
14. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
15. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
Ben Ayed-Guerfali D; Ben Kridis-Rejab W; Ammous-Boukhris N; Ayadi W; Charfi S; Khanfir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
J Transl Med; 2021 Mar; 19(1):108. PubMed ID: 33726785
[TBL] [Abstract][Full Text] [Related]
16. Possible association of the BRCA2 gene C5972T variant with gastric cancer: a study on Polish population.
Ławniczak M; Jakubowska A; Białek A; Karpińska-Kaczmarczyk K; Lubiński J; Starzyńska T
Pol Arch Med Wewn; 2015; 125(1-2):39-45. PubMed ID: 25533971
[TBL] [Abstract][Full Text] [Related]
17. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.
Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T
Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485
[TBL] [Abstract][Full Text] [Related]
18. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
[TBL] [Abstract][Full Text] [Related]
19. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.
Maia AT; Antoniou AC; O'Reilly M; Samarajiwa S; Dunning M; Kartsonaki C; Chin SF; Curtis CN; McGuffog L; Domchek SM; ; Easton DF; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Eccles D; ; Sinilnikova OM; Mazoyer S; Stoppa-Lyonnet D; Gauthier-Villars M; Faivre L; Venat-Bouvet L; Delnatte C; Nevanlinna H; Couch FJ; Godwin AK; Caligo MA; ; Barkardottir RB; ; Chen X; Beesley J; Healey S; Caldas C; Chenevix-Trench G; Ponder BA
Breast Cancer Res; 2012 Apr; 14(2):R63. PubMed ID: 22513257
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.
Yao S; Li W; Liu S; Cai Y; Zhang Q; Tang L; Yu S; Jing Y; Yin X; Cheng H
Cancer Med; 2023 Mar; 12(5):5209-5221. PubMed ID: 36200595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
